Type 2 & other diabetes

Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes

Endocr PractPublished Prospective cohort study

Authors' conclusion

By performing an OGTT in patients with IFG, an 1h-PG ≥ 155 mg/dL value may be helpful to predict T2DM at 7 years better than the use of MetS or the FINDRISC.

Study context

Population
Patients with impaired fasting glucose at a general hospital in Lima, Perú; mean age 56.2 ± 11.5 years, 64.0% women, 63.8% overweight/obese218 completed follow-up
Participants
324 patients
Exposure
1h-PG ≥155 mg/dL vs metabolic syndrome (MetS) vs Finish Diabetes Risk Score (FINDRISC) ≥13 for predicting T2D
Outcome
Development of T2D
Follow-up
7 years
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

T2D prediction
GroupAdjusted RRAUROC
1h-PG ≥ 155 mg/dL3.52 (95% CI 1.64-7.54)0.72 (0.60-0.83)
MetS1.81 (95% CI 0.96-3.38)0.63 (0.51-0.75)
FINDRISC ≥ 131.17 (95% CI 0.51-2.70)0.51 (0.38-0.63)

Adjusted RR

1h-PG ≥ 155 mg/dL3.52 (95% CI 1.64-7.54)
MetS1.81 (95% CI 0.96-3.38)
FINDRISC ≥ 131.17 (95% CI 0.51-2.70)

AUROC

1h-PG ≥ 155 mg/dL0.72 (0.60-0.83)
MetS0.63 (0.51-0.75)
FINDRISC ≥ 130.51 (0.38-0.63)
  • 1h-PG ≥ 155 mg/dL vs MetS: P = 0.01 — across the three AUROCs; also vs FINDRISC ≥ 13
Developed T2D
21.1%

Observational data: associations, not effects.

Further findings

Exposure among those who developed T2D · 7 years

Baseline prevalence of each exposure

Exposure among those who developed T2D — P, 1h-PG ≥ 155 mg/dL
P < .001
Exposure among those who developed T2D — P, MetS
P = .013
Exposure among those who developed T2D — P, FINDRISC ≥ 13
P = .68
  • Baseline prevalence of each exposure: 1h-PG ≥ 155 mg/dL with normal glucose tolerance

Original publication

Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes. Endocr Pract. Published 25 September 2024. doi:10.1016/j.eprac.2024.09.011

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.